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and Phl p 12 Specific IgE Antibodies in
the Sera of Children and Adult Patients
Allergic to Phleum Pollen
Alena Sekerkova1, Marta Polackova2 and Ilja Striz1
ABSTRACT
Background: Grasses belong to major sources of inhaled allergens. The knowledge of particular molecules
responsible for hypersensitivity is of crucial importance for better understanding of individual differences among
single allergic subjects and allergic populations living in various world-areas.
Methods: Specific-IgE-antibodies against Phl p 1, Phl p 5, Phl p 7, Phl p 12 were detected in a group of 130
Phleum-allergic-subjects (82 children, 48 adults).
Results: Phl p 1 antibodies were detected in most pediatric and adult patients, however, the children were as-
sociated with higher RAST classes more often. Anti-Phl p 5-antibodies were found more frequently in adults.
An increase was observed in the number of pediatric patients reacting to Phl p 7 and Phl p 12. There were no
differences in concentrations of specific-IgE against Phl p 5, Phl p 7 and Phl p 12 depending on age. Almost
10% of allergic children produced antibodies directed exclusively against minor allergens or did not produce
specific-IgE-antibodies against tested molecules. Part of the patients reacted to profilin and calcium-binding
protein originating from only one source (Phl p 12Bet v 2 and Phl p 7Bet v 4).
Conclusions: Antibodies against Phl p 1 and Phl p 5 can be used as a marker of allergy to grasses in adult
patients. Children reacted exclusively to minor allergens more frequently than adults. Prolonged allergen expo-
sure is evidently necessary to induce sensitization to Phl p 5. A high level of homology between profilins and
calcium-binding proteins enables only one allergen to be used for diagnostic purposes but a possibility of a re-
action to species-bound epitopes should be taken into account.
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INTRODUCTION
Grasses are an important source of inhaled aller-
gens.1,2 One of the reasons is a great amount of pol-
len produced by their species together with their
wide distribution in climatic zones, which are densely
populated. One of the significant grass allergens is
the Phleum pollen (Phleum pratense). Up to 20% of al-
lergic individuals worldwide are hypersensitive just to
the Phleum and related species of grasses of which
numerous cross-reactivities have been reported. Pol-
len allergens from various grass species are classified
into groups on the basis of their cross-reactivities.
Group I comprises allergens represented by the
major allergen of the Phleum, Phl p 1. Two isoforms
of a molecular weight of 35 and 37 kDa are desig-
nated as Phl p1.3,4 For example, pollens of wild
grasses and corn (rye grass, cocksfoot, fescue grass,
sweet vernal-grass and other grasses) are cross-
reactive allergens.5 The number of Phleum polli-
notics hypersensitive to group I varies between 70 to
100% in various countries in Europe.6 Because of the
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wide representation of group I allergens in grass pol-
lens and a high cross-reactivity of IgE antibodies
among group I allergens, the antibodies against Phl p
1 can be used as a diagnostic marker of the grass al-
lergy.
Another major group of grass allergens is group V
with allergens to which 60 to 93% of patients with pol-
linosis do react. Group V is represented by a Phl p 5
molecule. Two isoforms with a molecular weight of
38 kDa (Phl p 5a), 29 kDa andor 32 kDa (Phl p 5b)
are designated as Phl p 5. Each isoforms can be split
at least into 4 isoallergens. An area of a magnitude of
11.2 kDa at the N-terminal fragment was found as a
binding site for IgE in allergenic molecule Phl p 5a.
This area that contains more IgE-binding epitopes ex-
hibits a strong reactivity in up to 76% of Phleum aller-
gic individuals. Another IgE-binding area was found
at the C terminal-site of the protein.7-10 Phl p 5b in-
duces allergic and asthmatic manifestations in 90% of
grass pollinotics.
In addition to major allergens, specific IgE antibod-
ies are directed also against the minor allergens Phl p
7 and Phl p 12. Phl p 7 is an intracellular pollen pro-
tein with a molecular weight of 8.6 kDa.11 Antibodies
against the calcium-binding protein family were de-
tected in 5 to 10% of pollen allergic individuals. The
calcium-binding protein is also responsible for cross-
reactivities between pollens of grasses, trees and
weeds.12,13
Another group of allergenic molecules responsible
for cross-reactions between various species of plants
includes plant profilins designated as Phl p 12 in the
Phleum pollen. Profilins are present in all eukaryotic
cells of plant and animal origin. The molecular weight
of plant profilins is reported to be between 12 to 15
kDa. They are highly conserved molecules with nu-
merous homologies. The number of patients produc-
ing IgE antibodies against profilin were detected vari-
ably between 8 to 15% in Europe.6 Phl p 12 specific
IgE antibodies account for cross-reactions with ho-
mologous profilins in many other allergens in both
pollens and foods.14
The purpose of this study was to characterize the
profile of specific IgE antibodies against the major
(Phl p 1 and Phl p 5) and the minor (Phl p 7 and Phl p
12) Phleum allergens in the Czech Republic. Particu-
lar attention was paid to differences between the pedi-
atric and adult populations of the Phleum pollinotics.
Moreover, we focused on the reactivity of pollen aller-
gic individuals against recombinant profilins and
calcium-binding proteins from various plant species
(Bet v 2 × Phl p 12 and Bet v 4 × Phl p 7).
METHODS
STUDY SUBJECTS
During the years 2004-2009, the sera of 130 patients
with a case history of seasonal pollen allergy includ-
ing symptoms of allergic asthma or rhinoconjunctivi-
tis were collected. The tested group comprised 67
males and 63 females of whom 82 were children aged
1-18 years, (53 boys, 29 girls) and 48 adults aged 19-
70 years (14 males and 34 females). Criteria for the fi-
nal selection to the present study were patient history
(seasonal allergic rhinitis, rhinoconjunctivitis, sneez-
ing), positive skin prick test to Phleum pollen, labora-
tory parameters (increased total IgE, positive IgE re-
activity to Phleum pollen extract (g6) established by
FEIA as measured by Phadia CAPsystem (UniCap250
Firm Phadia, Uppsala, Sweden). Patients exhibiting a
concentration of specific IgE antibodies against
Phleum pollen higher than 0.35 kUl were evaluated
as positive and included in the study. IgE antibodies
against the major and minor Phleum pollen allergens
were tested before the vaccination therapy.
METHODS
Serum levels of allergen-specific IgE against recombi-
nant allergens Phl p 1, Phl p 5, Phl p 7, Phl p 12 were
measured by the FEIA method (UniCap250 Firm
Phadia) according to the instructions of the manufac-
turer. Diagnostics with birch pollen extract, recombi-
nant, Phl p 1, Phl p 5, Phl p 7, Phl p 12 are commer-
cially available. The evaluation was performed quanti-
tatively in kUl or by RAST scoring system.
Specific IgE antibodies against recombinant Bet v
2Phl p 12 respectively Bet v 4Phl p 7 were detected
in the sera of 30 patients (16 males and 14 females)
sensitized to profilin respectively 22 patients (12
males and 10 females) sensitized to calcium-binding
protein. Tests were performed using FEIA (Phadia
UniCap250 Firm).
All patients sera were analyzed in the laboratory of
the Faculty Hospital Bulovka, Prague. All tested pa-
rameters were requested by physicians as a part of
laboratory screening. The protocol was approved by
the Ethical Committee of the Faculty Hospital Bu-
lovka and included written informed consent of study
subjects and data management with patient anonym-
ity.
STATISTICS
Statistical analysis was performed using chi-square
test.
RESULTS
In sera of 130 patients exhibiting IgE antibodies
against the Phleum pollen (g6), IgE antibodies
against the major and minor Phleum allergens Phl p
1, Phl p 5, Phl p 7 and Phl p 12 were tested.
1SPECIFIC IgE ANTIBODIES AGAINST MAJOR
AND MINOR PHLEUM ALLERGENS IN PEDIAT-
RIC AND ADULT POPULATIONS
In the group of patients tested, the rate of occurrence
of specific IgE antibodies against the major and mi-
nor allergens of the Phleum was measured. Antibod-
IgE Phleum Reactivity Related to Age
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Fig.　1　Comparison of occurrence of specifi c IgE against major and minor Phleum pollen 
allergens in the pediatric and adult populations.
100
90
80
70
60
50
40
30
20
10
0
%
9.8 6.2
40.2
20.8
90.2 93.8
59.8
79.1
82.9 87.5
78.1 87.5
17.1 12.5
21.9 12.5
children adults
Phl p 1 Phl p 5 Phl p 7 Phl p 12
children adults children adults children adults
negative
positive
ies against Phl p 1 were found in the sera of 92% of
the patients, 69.5% of allergic individuals reacted
against the second major allergen Phl p 5, 14.8% of
the patients reacted against the minor allergens Phl p
7 (calcium-binding protein), and 16.6% against Phl p
12 (profilin). Attention was focused to the differences
in the rate of occurrence of specific IgE antibodies in
pediatric and adult populations. Tests were per-
formed in 82 children aged 0 to 18 and 48 adults over
18 years of age. No significant differences were found
between the children and adults as for the number of
patients with pollinosis reacting against Phl p 1 (90.2%
respectively 93.8%) (p = 0.714). However, when com-
paring patients with the presence of IgE antibodies
against Phl p 5, we found a 20% higher incidence in
the group of adult patients (p = 0.023) (59.8% of the
children, 79.1% of the adults). Antibodies against Phl
p 7 were detected in 17.1% of the children and 12.5%
of the adults (p = 0.486). Similarly, 21.9% of the chil-
dren and 12.5% of the adults reacted against Phl p 12
(p = 0.180). The results are summarized in Figure 1.
Concentrations of specific IgE antibodies against
major and minor Phleum allergens in pediatric and
adult populations are summarized in Table 1. The re-
sults were evaluated by RAST classes. In children,
the antibodies against Phl p 1 were evaluated by the
highest RAST classes (4-6) in 39.1%, whereas in adult
patients, only 25.1% of the sera tested reached these
values. On the other hand, no differences were found
in concentrations of specific IgE antibodies against
Phl p 5 in adult pollinotics (27.1%) as compared to the
tested children (23.2%). No differences between pedi-
atric and adult pollinotics were found in concentra-
tions of specific IgE against minor Phleum allergens.
2MONOSENSITIZATION ANDOR POLYSENSI-
TIZATION TO Phl p 1, Phl p 5, Phl p 7, Phl p 12 IN
PEDIATRIC AND ADULT POPULATIONS
In the tested group, a spectrum of specific IgE anti-
bodies against particular Phleum allergens was de-
tected. 71.4% of allergic individuals reacted exclu-
sively against major allergens. Antibodies against mi-
nor allergens were detected in 24.4% of the tested
sera in addition to antibodies against major allergens.
The last group was composed of patients (8.5%)
who did not exhibit detectable IgE antibodies against
major allergens while having antibodies against mi-
nor allergens (3.6%), or they did not have antibodies
against any of the tested molecules (4.9%), the positiv-
ity of IgE against the Phleum pollen being confirmed.
This group consisted only from allergic children.
In the spectrum of specific IgE, differences were
found between the group of the children and that of
the adults. The results are summarized in Table 2.
65.9% of the children and 76.9% of the adults reacted
exclusively against major allergens. In addition to an-
tibodies against major allergens, antibodies against
minor allergens were confirmed in 25.6% of the chil-
dren and in 23.1% of the adults.
Occurence of a high number of patients who in ad-
dition to antibodies against major allergens also have
antibodies against minor allergens or do not have an-
tibodies against major allergens at all should be taken
into consideration when choosing a hyposensibiliza-
tion treatment. Especially in the pediatric population,
the reactivity to minor allergens is relative high
(34.1% of pediatric pollinotics).
3SPECIFIC IgE ANTIBODIES AGAINST PRO-
FILIN (Bet v 2 AND Phl p 12) AND CALCIUM-
BINDING PROTEIN (Bet v 4 AND Phl p 7) FROM
THE BIRCH AND PHLEUM POLLEN
A high homology has been demonstrated between
Sekerkova A et al.
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Table　1　Percentage distribution of Phl p1, Phl p5, Phl p7 and Phl p12 specifi c-IgE (in RAST classes) in the sera of pediatric 
(82) and adult (48) Phleum pollen allergic subjects
Children
RAST classes 0 1 2 3 4 5 6 4-6
Phl p 1 9.8 3.7 19.5 28 19.5 9.8 9.8 39.1
Phl p 5 40.2 6.0 9.8 20.8 11.0 7.3 4.9 23.2
Phl p 7 82.9 3.7 6.1 1.2 2.4 0 3.7 6.1
Phl p 12 78 6.1 9.8 2.4 3.7 0 0 3.7
Adults
RAST classes 0 1 2 3 4 5 6 4-6
Phl p 1 6.3 4.2 29.2 35.3 14.6 6.3 4.2 25.1
Phl p 5 20.8 6.3 20.8 25 12.5 10.4 4.2 27.1
Phl p 7 87.4 2.1 6.3 2.1 2.1 0 0 2.1
Phl p 12 87.4 6.3 0 6.3 0 0 0 0
Specifi c IgE
 IU/l
RAST 
classes
<0.35 0
0.35-0.7 1
0.7-3.5 2
3.5-1.75 3
17.5-50 4
50-100 5
>100 6
Table　2　Monosensitization or/and polysensitization in the population of pediatric and adult Phleum pollen allergic individuals
Spectrum of Tested Allergens
Children % Adults %
Phl p 1+ Phl p 5-  Phl p 7- Phl p 12- 24.4
65.9
Phl p 1+ Phl p 5-  Phl p 7- Phl p 12- 20.7
76.9
Phl p 1+ Phl p 5+ Phl p 7- Phl p 12 - 41.5 Phl p 1+ Phl p 5+ Phl p 7- Phl p 12 - 56.2
Phl p 1+ Phl p 5+ Phl p 7+ Phl p 12 - 3.7
25.6
Phl p 1+ Phl p 5+ Phl p 7+ Phl p 12 - 6.3
23.1
Phl p 1+ Phl p 5+ Phl p 7+ Phl p 12+ 8.5 Phl p 1+ Phl p 5+ Phl p 7+ Phl p 12+ 6.3
Phl p 1+ Phl p 5+ Phl p 7- Phl p 12 + 4.9 Phl p 1+ Phl p 5+ Phl p 7- Phl p 12 + 4.2
Phl p 1+ Phl p 5-  Phl p 7- Phl p 12 + 4.9 Phl p 1+ Phl p 5-  Phl p 7- Phl p 12 + 0
Phl p 1+ Phl p 5-  Phl p 7+ Phl p 12+ 2.4 Phl p 1+ Phl p 5-  Phl p 7+ Phl p 12+ 0
Phl p 1-  Phl p 5+ Phl p 7- Phl p 12+ 0 Phl p 1-  Phl p 5+ Phl p 7- Phl p 12+ 2.1
Phl p 1-  Phl p 5+ Phl p 7- Phl p 12 - 1.2 Phl p 1-  Phl p 5+ Phl p 7- Phl p 12 - 4.2
Phl p 1-  Phl p 5-  Phl p 7- Phl p 12+ 1.2
 8.5
Phl p 1-  Phl p 5-  Phl p 7- Phl p 12+ 0
0Phl p 1-  Phl p 5-  Phl p 7+ Phl p 12- 2.4 Phl p 1-  Phl p 5-  Phl p 7+ Phl p 12- 0
Phl p 1-  Phl p 5-  Phl p 7- Phl p 12- 4.9 Phl p 1-  Phl p 5-  Phl p 7- Phl p 12- 0
profilins and calcium-binding proteins from various
species of plants because these are conserved pro-
teins with significant biological functions. We there-
fore focused attention on detecting the reactivity to
recombinant Bet v 2 and Bet v 4 molecules in patients
carrying detectable IgE antibodies against Phl p 7
and Phl p 12. The results show that 83.3% of the pa-
tients have detectable antibodies against the profilin
of both the Phleum and the birch (Bet v 2Phl p 12).
A number of patients (16.7%) synthetizes specific IgE
against profilin from one source only. Antibodies
against the Bet v 4Phl p 7 calcium-binding protein
were found in the sera of 78.6% of the patients. There
were 21.4% of the patients reacting exclusively
against one protein. The results are summarized in
Figure 2.
DISCUSSION
This study presents summarized results concerning
the rate of occurrence of specific IgE antibodies
IgE Phleum Reactivity Related to Age
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Fig.　2　Cross-reaction specifi c IgE among profi lin and calcium-binding 
protein from different sources.
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against major (Phl p 1, Phl p 5) and minor Phleum al-
lergens (Phl p 7 and Phl p 12) and their concentra-
tions in a group of Phleum pollen allergic individuals
living in the Czech Republic. Although population dif-
ferences in the reactivity of allergen specific IgE anti-
bodies in dependence on various areas of Europe and
the world are well documented, yet very little is
known about changes of the allergenic profile of the
population living in one area depending on age.6,15-17
Attention has therefore been focused on the differ-
ences between pediatric and adult patients regarding
their capacity to pathologically react to major and mi-
nor Phleum pollen allergens.
In most patients, antibodies against Phl p 1 corre-
sponded to the rate of occurrence of these antibodies
in Phleum pollen pollinotics in Europe.6 When com-
paring pediatric and adult pollinotics we have not
found a difference in the rate of occurrence of anti-
bodies. Children, however, have been associated with
higher RAST classes more frequently than adult pa-
tients. Higher concentrations of specific IgE antibod-
ies against Phl p 1 in children correspond with results
obtained by testing pediatric and adult birch pollen al-
lergic individuals against Bet v 1, Bet v 2 and Bet v
4.18
On the basis of a comparison of pediatric and adult
Phleum pollen allergic individuals we have found an
increase in the number of Phl p 12 positive findings in
children even when this increase was not so pro-
nounced as in testing the Bet v 2 specific IgE antibod-
ies in birch pollen pollinotics. It is possible that chil-
dren react preferentially to profilin epitopes which
are species-specific and we have therefore found cer-
tain differences in the number of allergic children re-
acting against Bet v 2 and Phl p 12. The results ob-
tained by the detection of Phl p 7 specific IgE anti-
bodies similarly show a tendency toward an increase
of positive findings in pediatric age which we have al-
ready observed when evaluating Bet v 4 antibodies.18
Surprisingly, a rapidly growing number of children
reacted with minor allergens responsible for cross-
reactions with pollens of unrelated species of plants
and plant-derived food. The reason of this higher re-
activity in children is unknown. The question is
whether this tendency relates to a change in the life
style, particularly to an insufficient stimulation by pre-
viously common allergens, e.g., of infectious origin
and to an increasing exposition of the children organ-
Sekerkova A et al.
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ism to chemical substances from environmental sur-
roundings and foods. Furthermore, the expansion of
ornamental plants and trees in densely populated ar-
eas which increased the allergenic burden of child’s
organism, may be responsible for growing number of
polyreactive allergies. Climate changes and environ-
mental industrialization may be another reason of
pathological reaction in children. It is, however, possi-
ble to state that there is an unambiguously increasing
trend to pathologically react to non-pathogenic anti-
gens whether of an exogenic or endogenic origin
(higher incidence of allergic and autoimmune dis-
ease).19-24
It is obvious that the suitability of classical hy-
posensibilization therapy of these patients by vac-
cines standardized by the content of major allergens
might be limited. Simultaneously in the patients,
where vaccination does not provide a protective long-
term effect, insufficient concentration of allergenic ac-
tive molecules in the applied extract might be a
cause.
Allergen extracts currently used in diagnostics and
the subsequent hyposensibilization are obtained from
natural sources. Their standardization is still prob-
lematic. Only in 1999, WHO issued a position paper
concerning the standardization of allergens. A final
goal is the use of extracts containing defined amounts
of major allergens. Most allergen extracts are thus
standardized only in the biological activity and a con-
centration of a major allergen, not minor allergens,
however (NIBSC Biological Reference Materials
1999).
The gradually expanding knowledge of molecular
and biochemical properties of allergen molecules
makes it possible to prepare these proteins syntheti-
cally to obtain highly purified and precisely character-
ized extracts of recombinant allergens which allow
“an allergenic profile” to be determined for each pa-
tient. The precise knowledge of the patient’s “aller-
genic profile” helps to choose a better targeted immu-
notherapy. The selection of an appropriate allergen
extract containing precisely defined amount of an in-
dividual active molecule andor molecules might lead
to optimization of immunotherapy and to reduction of
adverse side effects of possible newly formed specific
IgE antibodies.25 The relatively high number of chil-
dren with minor allergen antibodies, strengthen us in
the view that allergenic profile examination should
precede initiation of vaccination therapy and should
become one of the criteria for the decision to initiate
allergen immunotherapy. It is also the question of
whether standardized vaccines for minor allergens
would not be appropriate to produce.
Phl p 5 was the only recombinant allergen tested in
which we have found higher sensibilization in the
adult population. Likewise, we have demonstrated
that adult pollinotics were evaluated by higher RAST
classes more frequently than children. With respect
to the fact that in the neighbouring countries (Aus-
tria, Germany) Phl p 5 is detected in up to 90% of the
patients tested, a longer-lasting allergen exposure is
undoubtedly necessary for the development of sensi-
bilization. It is possible that articles addressing the is-
sue of allergies to Phleum involved preferentially
adults since no data were shown regarding the aver-
age age of patients.6 Considering that when testing
specific antibodies against major and minor Phleum
and birch allergens we have always found the same
or a significantly higher reactivity of allergic children
this phenomenon should be studied further and the
occurrence of Phl p 5 IgE antibodies in individual age
categories should be investigated in more detail. One
of the possible explanations of why a prolonged expo-
sure is necessary before sensibilization was elicited
could be a different mode of binding and internaliza-
tion of Bet v 1 and Phl p 1 by mucosal Langerhans
cells in contrast to Phl p 5. Bet v 1 and Phl p 1 are
likely absorbed by micropinocytosis, without detect-
able receptor binding.26 Phl p 5 is likely to bind to a
receptor (e.g., FcepsilonRl) required for its internali-
zation. In this case, the presence of allergen-specific
IgE antibodies bound to Fcepsilon at the cell surface
would be necessary for the internalization and pres-
entation of the allergen by immunocompetent cells.
There is a speculation as to whether this is a general
phenomenon or whether receptor binding occurs
only in internalization by Langerhans cells.27 There is
a question of whether various allergens are absorbed
and consequently presented by immunocompetent
cells by quite a different mode. This could affect not
only the development of allergy but also the success
of sublingual immunotherapy.
It is known that plant profilins are, due to their bio-
logical function, very conserved molecules exhibiting
a high homology. Nevertheless, it has been de-
scribed that up to 60% of specific IgE react with pro-
filin epitopes which are species-specific.28 A high de-
gree of homology between particular molecules of
profilins makes it possible to use one profilin for diag-
nostics, however, it is necessary to take into account
the possibility that specific IgE can be bound to
species-specific epitopes. IgE antibodies binding to
species-specific epitopes of profilin are likely to be
less responsible for cross-reactions with food aller-
gens.
Calcium-binding proteins (Phl p 7 and Bet v 4),
which also exhibit high homology, are strongly cross-
reactive. Patients with IgE directed against epitopes
of the calcium-binding protein are a group of allergic
subjects exhibiting a polysensitivity against various
unrelated species of plants (trees, grasses, weeds).
On the other hand, significant structural differences
have been identified.13 It can be assumed that even
calcium-binding proteins contain conserved epitopes
which are widely spread in many species and are re-
sponsible for the cross-reactivity of specific IgE anti-
IgE Phleum Reactivity Related to Age
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bodies and epitopes with species-bound areas. Almost
a quarter of the tested allergic subjects had specific
IgE antibodies exclusively directed against one of
them.
In conclusion, it can be stated that IgE antibodies
against Phl p 1 and Phl p 5 might be used as a reliable
marker of allergy to grasses in adult patients in par-
ticular. One part of pediatric patients reacts only to
minor allergens and their future profile of allergen-
specific antibodies is unclear. Whether the reactivity
against minor allergens will be persist should be
evaluated after several years. There is also a possibil-
ity of upregulation of specific IgE antibodies. Further-
more, some of these allergens are responsible for
cross-reactivity between pollens and plant food, there-
fore we consider these findings as quite important
with respect to an increase of food allergies in chil-
dren worldwide.29-31
The high degree of homology between profilins
and calcium-binding proteins allows only one allergen
to be used for the diagnostic purposes, however, the
possibility of an allergic reactivity to species-bound
epitopes needs to be taken into account with respect
to a design of future vaccines.
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